Previous investigations of the subjective effects of MDMA (material sold as ecstasy) have conducted interviews and surveys of various groups of ecstasy users within particular sub-populations. This study examined subjective drug effects reported by different sub-populations of ecstasy users and explored whether the function or purpose served by using ecstasy influenced the nature of the drug experience. Drawing on previous measures of alterations in consciousness, psychedelic drugs and cannabis, and informal interviews with ecstasy users and MDMA researchers, a 130-item survey assessing subjective effects of ecstasy/MDMA was developed. Principal components analysis of responses of ecstasy users revealed six components; perceptual alterations, entactogenic effects, prosocial effects, aesthetic effects, negative effects and sexual effects. The derived scale was used to predict ecstasy use behaviours, and functions and experiences of use. A variety of component scores were related to ecstasy use parameters; in particular, heavier users expected fewer negative, perceptual and aesthetic effects from taking the drug. The reasons given for using ecstasy (use function) also influenced reported drug effects. Abstainers expected greater negative, perceptual, aesthetic and sexual effects than users. These data indicate that the subjective ecstasy experience is influenced by a variety of extra-psychopharmacological factors. Drug intervention strategies may be made more effective by targeting particular user groups defined by reasons given for substance use, as it is likely that their experiences of ecstasy effects will differ. Future research into ecstasy may be improved by recognizing user diversity.
Aust R , Sharp C , Goulders C (2003) Prevalence of drug use: key findings from the 2001/2002 British Crime Survey. 182. Home Office Research Findings, Home Office, London
2.
Baggott M J (2002) Preventing problems in Ecstasy users: reduce use to reduce harm . Journal of Psychoactive Drugs34: 145–162
3.
Baggott M , Heifets B , Jones R T , Mendelson J , Sferios E , Zehnder J (2000) Chemical analysis of ecstasy pills . Journal of the American Medical Association284: 2190-2190
4.
Boys A, Marsden J (2003) Perceived functions predict intensity of use and problems in young polysubstance users . Addiction98: 951–963
5.
Boys A , Marsden J , Strang J (2001) Understanding reasons for drug use among young people: a functional perspective . Health Education and Research16: 457–469
6.
Boys A , Marsden J , Griffiths P , Fountain J , Stillwell G , Strang J (1999) Substance use amongst young people: the relationship between perceived functions and intentions . Addiction94: 1043–1050
7.
Butler G K , Montgomery A M (2004) Impulsivity, risk taking, and recreational ‘ecstasy’ (MDMA) use . Drug and Alcohol Dependence76: 55–62
8.
Cami J , Farre M , Mas M , Roset P N , Poudevida S , Mas A , San L, de la Torre R (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (‘ecstasy’): psychomotor performance and subjective effects . Journal of Clinical Psychopharmacology20: 455–466
9.
Cohen R S (1995) Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans . Progress in Neuropsychopharmacology and Biological Psychiatry19: 1137–1145
10.
Cole J C , Sumnall H R (2003a) Altered states: the clinical effects of Ecstasy . Pharmacology and Therapeutics98: 35–58
11.
Cole J C , Sumnall H R (2003b) The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) . Neuroscience and Biobehavioural Reviews27: 199–217
12.
Cole J C , Sumnall H R , Grob C S (2002a) Sorted: ecstasy facts and fiction . The Psychologist15: 464–474
13.
Cole J C , Bailey M , Sumnall H R , Wagstaff G F , King L A (2002b) The content of ecstasy tablets: implications for the study of their long-term effects . Addiction97: 1531–1536
14.
Condon J , Smith N (2003) Prevalence of drug use: key findings from the 2002/2003 British Crime Survey. 229-229. Home Office, London .
15.
Curran H V , Travill R A (1997) Mood and cognitive effects of 3,4-meth-ylenedioxymethamphetamine (MDMA, ‘ecstasy’): week-end ‘high’ followed by mid-week low . Addiction92: 821–831
16.
Curran H V , Rees H , Hoare T , Hoshi R , Bond A (2004) Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users . Psychopharmacology173: 425–433
17.
Davison D , Parrott A C (1997) Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects . Human Psychopharmacology12: 221–226
18.
Fantegrossi W E , Woolverton W L , Kilbourn M , Sherman P , Yuan J , Hatzidimitriou G , Ricaurte G A , Woods J H , Winger G (2004) Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys . Neuropsychopharmacology29: 1270–1281
19.
Fendrich M , Wislar J S , Johnson T P , Hubbell A (2003) A contextual profile of club drug use among adults in Chicago . Addiction98: 1693–1703
20.
Field A (2000) Discovering statistics using SPSS for Windows. Sage, London
21.
Forsyth A J (1996) Places and patterns of drug use in the Scottish dance scene . Addiction91: 511–521
22.
Fraioli S , Crombag H S , Badiani A , Robinson T E (1999) Susceptability to amphetamine-induced locomotor sensitization is modulated by environmental stimuli . Neuropsychopharmacology20: 533–541
23.
Gamma A , Jerome L , Liechti M , Sumnall H R (2005) Is ecstasy perceived to be safe? A web based survey and review of the literature . Drug and Alcohol Dependence77: 185–193
24.
Green A R , Mechan A O , Elliott J M , O'Shea E , Colado M I (2003) The pharmacology and clinical pharmacology of 3,4-methylene-dioxymethamphetamine (MDMA, ‘ecstasy’) . Pharmacological Reviews55: 463–508
25.
Greer G R , Tolbert R (1998) A method of conducting therapeutic sessions with MDMA . Journal of Psychoactive Drugs30: 371–379
26.
Hansen D , Maycock B , Lower T (2001) ‘Weddings, parties, anything...’, a qualitative analysis of ecstasy use in Perth, Western Australia . International Journal of Drug Policy12: 181–199
27.
Harris D S , Baggott M , Mendelson J H , Mendelson J E , Jones R T (2002) Subjective and hormonal effects of 3,4-methylenedioxymethampheta-mine (MDMA) in humans . Psychopharmacology162: 396–405
28.
Hermle L , Spitzer M , Borchardt D , Kovar K A , Gouzoulis E (1993) Psychological effects of MDE in normal subjects: are entactogens a new class of psychoactive agents?Neuropsychopharmacology8: 171–176
29.
Holland J (2001) Ecstasy: The Complete Guide. Park Street Press, Rochester, VT
30.
Jaccard J , Wan C K (1996) LISREL approaches to interaction effects in multiple regression. Sage Publications, Thousand Oaks, CA
31.
Johnston L D , O'Malley P M , Bachman J G (2002) Rise in ecstasy use among American teens begins to slow. University of Michigan News and Information Services, Ann Arbor, MI
32.
Liechti M E , Vollenweider F X (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies . Human Psychopharmacology16: 589–598
33.
Liechti M E , Gamma A , Vollenweider F X (2001a) Gender differences in the subjective effects of MDMA . Psychopharmacology154: 161–168
34.
Liechti M E , Geyer M A , Hell D , Vollenweider F X (2001b) Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin . Neuropsychopharmacology24: 240–252
35.
Liester M B , Grob C S , Bravo G L , Walsh R N (1992) Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use . Journal of Nervous and Mental Disease180: 345–352
36.
MacAndrew C , Edgerton R B (1969) Drunken Comportment: A Social Explanation, 1st edn.Aldine Publishing Company, Chicago, IL
37.
McDermott P (1993) MDMA use in the north west of England . International Journal of Drug Policy4: 210–221
38.
Metzner R , Adamson S (2001) Using MDMA in Healing, Psychotherapy and Spiritual Practice. In Holland J (ed.), Ecstasy: The complete guide. Inner Traditions, Rochester, VT , pp. 182–207
39.
Mithoefer M (2003) MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder (PTSD): a third update on the approval process . MAPS Bulletin13: 7–8
40.
Navarro J F , Maldonado E (2002) Acute and subchronic effects of MDMA (‘ecstasy’) on anxiety in male mice tested in the elevated plus-maze . Progress in Neuropsychopharmacology and Biological Psychiatry26: 1151–1154
41.
Pahnke W , Richards W (1966) Implications of LSD and experimental mysticism . Journal of Religion and Health5: 175–208
42.
Parrott A C , Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance . Psychopharmacology139: 261–268
43.
Parrott A C , Stuart M (1997) Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users . Human Psychopharmacology12: 501–504
44.
Parrott A C , Milani R M , Parmar R , Turner J D (2001) Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems . Psychopharmacology159: 77–82
45.
Peroutka S J , Newman H , Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users . Neuropsychopharmacology 1: 273–277
46.
Rhodes T (1996) Culture, drugs and unsafe sex: confusion about causation . Addiction91: 753–758
47.
Schafer J , Brown S A (1991) Marijuana and cocaine effect expectancies and drug-use patterns . Journal of Consulting and Clinical Psychology59: 558–565
48.
Scholey A B , Parrott A C , Buchanan T , Heffernan T M , Ling J , Rodgers J (2004) Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study . Addictive Behaviours 29: 743–752
49.
Shewan D , Dalgarno P , Reith G (2000) Perceived risk and risk reduction among ecstasy users; the role of drug, set and setting . International Journal of Drug Policy10: 431–453
50.
Siegel R K (1986) MDMA. Nonmedical use and intoxication . Journal of Psychoactive Drugs18: 349–354
51.
Solowij N , Hall W , Lee N (1992) Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug . British Journal of Addiction87: 1161–1172
52.
Stevens S (1997) Speaking the silence: MDMA in a couple dealing with cancer . MAPS Bulletin7: 6–10
53.
Stevens S (1999) MDMA in a couple struggling with cancer: Two years later . MAPS Bulletin, 9: 15–17
54.
Stevens S (2000) MDMA and a couple struggling with cancer: Sue's final letter . MAPS Bulletin9: 31–34
55.
Stolaroff M J (1997) The Secret Chief: Conversations with a pioneer of the underground psychedelic therapy movement. MAPS, Charlotte, NC
56.
Sumnall H R , Wagstaff G F , Cole J C (2004) Self-reported psychopathology in polydrug users . Journal of Psychopharmacology18: 63–69
57.
Tancer M , Johanson C E (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP . Drug and Alcohol Dependence72: 33–44
58.
Tart C (1977) On being stoned. Science and Behavior Books, Palo Alto
59.
Topp L , Hando J , Dillon P , Roche A , Solowij N (1999) Ecstasy use in Australia: patterns of use and associated harm . Drug and Alcohol Dependence55: 105–115
60.
Tossmann P , Boldt S , Tensil M D (2001) The use of drugs within the techno party scene in European metropolitan cities . European Addiction Research7: 2–23
61.
Verheyden S L , Henry J A , Curran H V (2003) Acute, subacute and longterm subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users . Human Psychopharmacology18: 507–517
62.
Vogel-Sprott M , Fillmore M (1999) Expectancy and behavioural effects of socially used drugs. In Kirsch I (ed.), Expectancy, Experience, and Behavior. American Psychological Association, Washington, DC
63.
von Sydow K , Lieb R , Pfister H , Hofler M , Wittchen H U (2002) Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study . Drug and Alcohol Dependence66: 147–159
64.
Watson L , Beck J (1991) New age seekers: MDMA use as an adjunct to spiritual pursuit . Journal of Psychoactive Drugs23: 261–270
65.
Williams L , Parker H (2001) Alcohol, cannabis, ecstasy and cocaine: drugs of reasoned choice amongst young adult recreational drug users in England . International Journal of Drug Policy12: 397–413
66.
Zacny J P , Virus R M , Woolverton W L (1990) Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine . Pharmacology, Biochemistry, and Behaviour35: 637–642
67.
Zemishlany Z , Aizenberg D , Weizman A (2001) Subjective effects of MDMA (‘Ecstasy’) on human sexual function . European Psychiatry16: 127–130
